Recent Posts
- FDA Okays Blood Test for Ovarian Cancer
- Replication At DNA Damage Sites Highlights Fanconi Anemia And Breast Cancer Proteins
- ASCO To Hold Annual Meeting In Chicago For The Next Ten Years: City Seen As Best Choice To Host Meeting That Continues To Grow
- Protein Partnership Leads To Pediatric Tumor Regression
- ASCO Awarded CEO Cancer Gold Standard: Achievement Underscores Organization’s Commitment To The Health And Well-Being Of Its Employees
Random Posts
- Leukemia: A Home Run and a Long Touchdown Drive
- Metabolomics Used To Identify The Mechanism Of Action Of An Anti-Cancer Drug
- XMRV Is Present In Malignant Prostatic Epithelium And Is Associated With Prostate Cancer, Especially High-Grade Tumors
- Free Prostate Cancer Screening Offered In Camden Oct. 10
- CytRx's Tamibarotene Demonstrates Statistically Significant Anti-Tumor Activity In Animal Trial For Multiple Myeloma
- Mammography Guidelines Intensify Healthcare Reform Debate
- A Potential Drug For Liver Carcinoma
- ASCO: DNA Repair Gene Predicts Chemo Outcome in Lung Cancer
- USC Awarded New $16 Million Cancer Research Center
- Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion's Global Phase III ThermoDox(R) Trial For Primary Liver Cancer
Prescription Cancer Drugs
Australian Researchers Identify Genes That Cause Melanoma
Posted by: admin in Prescription Cancer Drugs on July 19th, 2009
Scientists from the Queensland Institute of Medical Research (QIMR) have found two new genes that together double a person’s risk of developing melanoma.
As part of an international study, a team at QIMR, led by Professors Nick Hayward and Grant Montgomery, studied the genes of almost 6,000 people together with their mole count. Specific changes in two genes were found to make people more susceptible to developing moles. The researchers went on to show, in another 4,000 people, the same two genes increased the risk of developing melanoma - the most deadly form of skin cancer.
“These are the first genes found to increase melanoma risk by influencing the number of moles a person has,” explained Professor Hayward. “This finding improves our understanding of the genetics of melanoma and therefore the molecular pathways that lead to its development.”
“It has long been known that having a large number of moles is the biggest risk factor. Therefore we predicted we would find genes linking moles and melanoma. We now have conclusive genetic evidence that having a large number of moles increases an individual’s risk of developing melanoma.”
The study found that people who carry one of these two gene variants have a 25% increased chance of developing melanoma, while for individuals carrying both variants their risk is doubled.
“In the long term, this research will be useful in developing screening techniques, and will also allow us to identify potential new drug targets and ultimately develop new therapies to treat melanoma,” said Professor Hayward.
Moles are normal but people should seek advice from their doctor if they observe any changes in size, colour or shape. People with lots of moles are at a higher risk of developing melanoma and should therefore take extra care to avoid overexposure to ultraviolet radiation.
Australia has the highest incidence of melanoma in the world with more than 10,000 new cases and 1000 people dying from the disease every year. Queensland has the highest incidence of any state with seven Queenslanders diagnosed with melanoma every day. More than one in 20 Queenslanders is expected to develop melanoma during their lifetime.
The collaborative research involved scientists from the Queensland Institute of Medical Research, King’s College London and The University of Leeds.
The study was funded by the US National Institutes of Health and the Australian National Health and Medical Research Council (NHMRC) and published in Nature Genetics.
Source:
Sarah Tennant
Research Australia
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.





